<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>West Asia Organization for Cancer Prevention (WAOCP), APOCP's West Asia Chapter.</PublisherName>
				<JournalTitle>Asian Pacific Journal of Cancer Prevention</JournalTitle>
				<Issn>1513-7368</Issn>
				<Volume>14</Volume>
				<Issue>11</Issue>
				<PubDate PubStatus="epublish">
					<Year>2013</Year>
					<Month>11</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Senescence Effects of Angelica sinensis Polysaccharides on Human Acute Myelogenous Leukemia Stem and Progenitor Cells</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>6549</FirstPage>
			<LastPage>6556</LastPage>
			<ELocationID EIdType="pii">28331</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>1970</Year>
					<Month>01</Month>
					<Day>01</Day>
				</PubDate>
			</History>
		<Abstract>Leukemia stem cells (LSCs) play important roles in leukemia initiation, progression and relapse, and thusrepresent a critical target for therapeutic intervention. Hence, it is extremely urgent to explore new therapeuticstrategies directly targeting LSCs for acute myelogenous leukemia (AML) therapy. We show here that Angelicasinensis polysaccharide (ASP), a major active component in Dong quai (Chinese Angelica sinensis), effectivelyinhibited human AML CD34+CD38− cell proliferation in vitro culture in a dose-dependent manner while sparingnormal hematopoietic stem and progenitor cells at physiologically achievable concentrations. Furthermore, ASPexerted cytotoxic effects on AML K562 cells, especially LSC-enriched CD34+CD38− cells. Colony formation assaysfurther showed that ASP significantly suppressed the formation of colonies derived from AML CD34+CD38−cells but not those from normal CD34+CD38− cells. Examination of the underlying mechanisms revealed thatASP induced CD34+CD38− cell senescence, which was strongly associated with a series of characteristic events,including up-regulation of p53, p16, p21, and Rb genes and changes of related cell cycle regulation proteins P16,P21, cyclin E and CDK4, telomere end attrition as well as repression of telomerase activity. On the basis of thesefindings, we propose that ASP represents a potentially important agent for leukemia stem cell-targeted therapy.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Angelica sinensis polysaccharide</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">leukemia stem/progenitor cells</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">senescence</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Telomerase</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Telomere</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://journal.waocp.org/article_28331_fbc567dcf31462b7263c292bd501ffc8.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
